After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Arrowhead Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc is $5.18B. A total of 2.69 million shares were traded on the day, compared to an average of 2.48M shares.
In the most recent transaction, Hamilton James C sold 20,000 shares of ARWR for 35.00 per share on Oct 01 ’25. After the transaction, the Chief Medical Officer now owns 212,122 company shares. In a previous transaction on Oct 01 ’25, James Hamilton bought 20,000 shares at 35.00 per share.
Among the insiders who sold shares, Hamilton James C disposed of 15,000 shares on Sep 12 ’25 at a per-share price of $30.00. This resulted in the Chief Medical Officer holding 232,122 shares of ARWR after the transaction. In another insider transaction, Hamilton James C bought 15,000 shares at $30.00 per share on Sep 12 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ARWR has a high of $36.24 and a low of $9.57.
As of this writing, ARWR has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.69 per share and a lower estimate of -$1.18. The company reported an EPS of -$1.37 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $3.78, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
